Summary
Overview
Work History
Education
Skills
Certification
Timeline
web

Lisa LaPoint

Surfside Beach,SC

Summary

Results-oriented Oncology/Hematology Consultant with a distinguished 28-year career in the pharmaceutical industry, starting with Zeneca in 1995 and specializing in the sales of oncology products within the Oncology and Urology markets. Extensive knowledge of Lung, GU, Melanoma and Lymphoma disease states. A seasoned professional with a versatile background, encompassing roles as a sales manager, hospital sales representative, territory manager, and field sales trainer. Demonstrates a high level of competencies in Managed Care and Healthcare Systems, adept at navigating the dynamic landscape of healthcare markets. Proven track record of success in driving sales and fostering strategic relationships within the oncology and hematology therapeutic areas.

Overview

28
28
years of professional experience
1
1
Certification

Work History

Health Systems Director

Sobi Inc.
04.2024 - 11.2024
  • Accountable for working cross-functionally to help ensure access to therapy for pediatric patients with rare disease state, by engaging with physicians, pharmacists and external experts. Certified for Gamifant.
  • Developed and executed business plans targeting multiple stakeholder groups in Texas & Oklahoma.
  • Developed and executed account plans based on national and regional strategies.
  • Responsible for sharing on-label scientific information that translated into real world practice.
  • On track with stated MBOs and led the region in active patient prescriptions.

Hematology Consultant

Bristol Myers Squibb
08.2022 - 08.2023
  • BMS eliminated the hematology division B I was working in. I did not receive a year end performance review.
  • Promoted Opdualag and Breyanzi in community based oncology accounts. Certified for Revlimid, Pomalyst and Sprycel.
  • Dec' 2022 Hematology Regional rank 1/14, National Rank 5/119.
  • POMALYST New Rx RMM contest, increased 1.20 cycles average dispense per patient over Q1.
  • SW Region Representative for Integrity Champion role, supporting an ethical work culture at BMS.
  • Pilot participant in MyGrowth@BMS an innovative artificial-intelligence-enabled talent marketplace platform will help us all re-imagine career development at BMS.

Hematology Consultant

TG Therapeutics
12.2020 - 01.2022
  • TG downsized the Hematology division in January 2022 – I did not receive a year end performance review or any sales documents. Promoted UKONIQ (umbralisib) Follicular Lymphoma and Marginal Zone Lymphoma 2/21.
  • Successfully gained P & T formulary approval at MD Anderson Cancer Center 9/2021.
  • Scheduled and effectively utilized virtual platform to share clinical data with HCP's.
  • Recognition for post launch sales at MD Anderson and VA as well as regional accounts.
  • Lead District in Q4 sales 2021.

Clinical Oncology Specialist Immunotherapy

Astra Zeneca Pharmaceuticals
10.2016 - 12.2020
  • Promoted Imfinzi (durvalumab) Urothelial Carcinoma and Stage III unresectable NSCLC. Promoted Tagrisso (osimertinib) Stage IV NSCLC EGFR+.
  • Texas Medical Center including MD Anderson, Methodist, Memorial Hermann, Baylor, VA, Oncology Consultants, Texas Oncology.
  • Successfully gained formulary approval for Imfinzi in UC and NSCLC at MD Anderson Cancer Center - 12/2017.
  • November 2019 GEO Report Tagrisso Goal Attainment 96.96%, Imfinzi Goal Attainment 128.41%.

Oncology Key Account Manager

Boehringer-Ingelheim Pharmaceuticals
05.2015 - 10.2016
  • Promotion of Gilotrif (afatinib) in advanced non-small cell lung cancer to medical oncologist in the Texas Medical Center including MD Anderson, Methodist, Baylor, Memorial Hermann, Oncology Consultants, Texas Oncology, Kelsey-Seybold, and VA.
  • Sales performance: Q1-141.22%, Q2-128.78%, Q3-117.46, YTD 2016 135.
  • Invited by leadership to attend World Lung Conference in Austria.

Executive Representative II, Oncology

Astellas Pharmaceuticals, US
04.2014 - 05.2015
  • Promotion of Tarceva (erlotinib) for NSCLC covering key healthcare providers in the Houston medical center, Greater Houston Metropolitan, Corpus Christi, San Antonio & Beaumont.
  • Executed complete office calls including customer focused selling that provide evidence based clinical data, patient education and reimbursement resources.
  • Collaborate with internal Astellas partners as well as external Genentech partners.
  • Coordinated with Lung Alliance and MD Anderson to organize and promote the first Lung Love Walk in Houston on November 8, 2014.

Senior Executive Representative

Astellas Pharmaceuticals, US
10.2009 - 04.2014
  • Focus includes: infectious diseases, leukemia, lymphoma, myeloma, critical care & pharmacy
  • Successfully launched Televancin in 2009.
  • Ranked 5/148 (2010) and 5/132 (2011)
  • Mycamine- #1 sales volume account in the nation MD Anderson Cancer Center MS growth 6% in 2001 to 60% in 2013.
  • 2013 Ivan Martinez Community Service Award - National recognition for outstanding dedication to community service and keeping with the Astellas commitment to Changing Tomorrow.
  • 2012 Mycamine formulary conversion at the VA
  • 2011 Area MAX Award for exceptional performance selected by area leadership team
  • 2010 Televancin Formulary win at MD Anderson

Hospital Account Manager

Wyeth
07.2008 - 10.2009
  • Increased sales of product portfolio in the IV anti-infective market by leveraging relationships with infectious diseases, surgery, critical care, hospitalist and pharmacy.
  • (Moved into Hospital Account Sales in July 2008 due to a contraction of Primary Care sales force as a District Manager. Received priority placement in promoted position in the Institutional Business Unit).

District Manager

Wyeth
02.2006 - 07.2008
  • Manage eight member district of TM/TR's
  • Coached/mentored district's first President's Recognition Achievement Award winner in 2007
  • Effectively coach TM/TR's in communicating and presenting product message, assisting in product knowledge and executing established policies and procedures
  • Develop business plan for district and monitor individual contributions, assist in TM/TR development planning to achieve individual and district sales goals
  • 2008 Career Development Promotion, DM level II
  • 2007 Moved district ranking to 9/50 from 47/50 ranking

Area Account Manager

Wyeth
05.1998 - 02.2006
  • Development of faculty and residents in understanding of promoted products and identifying thought leaders in specific specialties within the Texas Medical Center and surrounding community hospitals, including MD Anderson and UT Hermann
  • Appointed as the Area Field Trainer 3 years
  • 2004 Gained business planning & coaching experience through Area District Coordinator rotation
  • Ranked 5/148 (2010) and 5/132 (2011)
  • 2006 Tygacil Formulary win Memorial Hermann System & MD Anderson Cancer Center
  • 2006 Above and Beyond Recognition Award for exceptional results and leadership
  • 2005 Awarded Area “Fred Factor” for making a difference everyday by creating value with customers, successfully building strong relationships and constantly developing and growing personally and professionally.
  • 2004 STARRS Area Award for exceptional sales results
  • 2001 Protonix IV Formulary win at UTMB & CHRISTUS Spohn Health System
  • 2001 President's Leadership Award Winner

Territory Manager

Wyeth
11.1996 - 05.1998
  • Finalist in Naprelan sales contest in 1998
  • Attained ranking of 7/149 (1997) in sales ranking through strategic targeting of PCP's, executing marketing strategies and coordinating educations events.

Education

Bachelor of Business Administration, BBA -

Stephen F. Austin State University
Nacogdoches, Texas

Skills

  • Leadership
  • Relationship Orientation
  • Team Building
  • Product Launch
  • Market Access
  • Sales Effectiveness

Certification

  • CMR Institute Certification
  • Certified Dale Carnegie Sales Development

Timeline

Health Systems Director

Sobi Inc.
04.2024 - 11.2024

Hematology Consultant

Bristol Myers Squibb
08.2022 - 08.2023

Hematology Consultant

TG Therapeutics
12.2020 - 01.2022

Clinical Oncology Specialist Immunotherapy

Astra Zeneca Pharmaceuticals
10.2016 - 12.2020

Oncology Key Account Manager

Boehringer-Ingelheim Pharmaceuticals
05.2015 - 10.2016

Executive Representative II, Oncology

Astellas Pharmaceuticals, US
04.2014 - 05.2015

Senior Executive Representative

Astellas Pharmaceuticals, US
10.2009 - 04.2014

Hospital Account Manager

Wyeth
07.2008 - 10.2009

District Manager

Wyeth
02.2006 - 07.2008

Area Account Manager

Wyeth
05.1998 - 02.2006

Territory Manager

Wyeth
11.1996 - 05.1998

Bachelor of Business Administration, BBA -

Stephen F. Austin State University
Lisa LaPoint